Donglin Kuang

Transcatheter arterial chemoembolization plus apatinib with or without camrelizumab for unresectable hepatocellular carcinoma: a multicenter retrospective cohort study

Xuhua Duan, Hao Li, Donglin Kuang et al. · Hepatology International · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Xuhua Duan, Hao Li, Donglin Kuang et al. · Signal Transduction and Targeted Therapy · 2024 · 25 citations · Full text

Medicine, Oncology, Pharmacology +12

Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cells

Li Hao, Xinwei Han, Jianzhuang Ren et al. · European Journal of Pharmacology · 2018 · 21 citations

Life Sciences, Immunology, Oncology +10

Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study

Hao Li, Jiacheng Wang, Guokun Zhang et al. · Frontiers in Immunology · 2023 · 20 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma

Hao Li, Chao Liang, Donglin Kuang et al. · Cancer Biology & Therapy · 2023 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17